0001140361-24-037346.txt : 20240814 0001140361-24-037346.hdr.sgml : 20240814 20240814164138 ACCESSION NUMBER: 0001140361-24-037346 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240812 FILED AS OF DATE: 20240814 DATE AS OF CHANGE: 20240814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GKCC, LLC CENTRAL INDEX KEY: 0001977769 ORGANIZATION NAME: STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39990 FILM NUMBER: 241208926 BUSINESS ADDRESS: STREET 1: 501 SILVERSIDE ROAD STREET 2: SUITE 87AVA CITY: WILMINGTON STATE: DE ZIP: 19809 BUSINESS PHONE: (302) 992-8882 MAIL ADDRESS: STREET 1: 501 SILVERSIDE ROAD STREET 2: SUITE 87AVA CITY: WILMINGTON STATE: DE ZIP: 19809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chudnovsky Yekaterina CENTRAL INDEX KEY: 0001979324 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39990 FILM NUMBER: 241208927 MAIL ADDRESS: STREET 1: C/O ELICIO THERAPEUTICS, INC. STREET 2: 451 D STREET, 5TH FLOOR, SUITE 501 CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Elicio Therapeutics, Inc. CENTRAL INDEX KEY: 0001601485 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 113430072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 451 D STREET, 5TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: (857) 209-0050 MAIL ADDRESS: STREET 1: 451 D STREET, 5TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Angion Biomedica Corp. DATE OF NAME CHANGE: 20140228 4 1 form4.xml FORM 4 X0508 4 2024-08-12 0001601485 Elicio Therapeutics, Inc. ELTX 0001979324 Chudnovsky Yekaterina C/O ELICIO THERAPEUTICS, INC. 451 D STREET, 5TH FLOOR BOSTON MA 02210 true true 0001977769 GKCC, LLC 501 SILVERSIDE ROAD SUITE 87AVA WILMINGTON DE 19809 true false Convertible Note (convertible into Common Stock) 5.81 2024-08-12 4 P 0 3442341 5.81 A Common Stock 3442341 3442341 I Held by GKCC, LLC On August 12, 2024, GKCC, LLC (the "Purchaser") purchased from the Issuer a convertible note with an aggregate principal amount of $20,000,000 (the "Convertible Note"). The Convertible Note is convertible into shares of common stock of the Issuer at a conversion price of $5.81 per share, subject to adjustment in certain circumstances. Therefore, the Convertible Note is initially convertible into approximately 3,442,341 shares of common stock of the Issuer. The Convertible Note will mature on February 15, 2026, unless earlier converted in accordance with the terms of the Convertible Note. Interest on the Convertible Note is payable in cash and will accrue and be payable quarterly on the principal amount equal to 3% per annum. Yekaterina (Katie) Chudnovsky is the sole member and manager of the Purchaser and may be deemed to beneficially own the shares held by the Purchaser. /s/ Yekaterina Chudnovsky 2024-08-14 /s/ Yekaterina Chudnovsky, Manager GKCC, LLC 2024-08-14